MD Gergő A. Molnár
Professor, Deputy Head of Department
2nd Department of Internal Medicine and Nephrological Center
University of Pécs
Detailed program, abstracts, and certificate
The event will feature several scientific presentations. You can access the detailed program, the abstracts and the participation certificate here. Please note that the link is password-protected and intended solely for conference participants.
Saturday, 9 May
13:00 - 14:45
Registration
Hotel lobby
14:45 - 15:00
Welcome address
Konstantinos Makrilakis, Chair of the EDEG Steering Committee
Adam G. Tabák, Chair of the local organizing committee
15:00 - 15:45
Plenary session 1
Chair: Konstantinos Makrilakis
Speaker: Gergő A. Molnár
Title: The epidemiology of diabetes mellitus in Hungary: Results of the Hungarian Diab-EPI project
15:45 - 16:45
Oral presentations (Session 1)
Title: Descriptive epidemiology of diabetes mellitus
Chair: Gergő A. Molnár
OP1 Helene Nielsen: Mortality rates are not higher among persons with diabetes compared to persons without diabetes in Greenland
OP2 Vanja Kosjerina: Long-term trends in cancer incidence among individuals with and without type 2 diabetes: a nationwide Danish register study, 1996–2022
OP3 Judit Somogyi: Incidence, Prevalence and Survival Impact of Type 2 Diabetes Mellitus, Cardiovascular Disease, Chronic Kidney Disease and their Combinations in Hungary: a Nationwide, Retrospective Study
OP4 Kalina Todorova: The evolution of diabetes incidence and prevalence during the past decade in Belgium: a cross sectional real-world observational study
16:45 - 17:15
Coffee break
17:15 - 18:15
Oral presentations (Session 2)
Title: Cardiovascular complications of diabetes
Chair: Peter Stella & Tinne Laurberg
OP5 Romain Meer: Peripheral medial and intimal arterial calcification and incident cardiovascular disease in patients at increased risk of cardiovascular disease: the prospective smart-artemis study
OP6 Shiqiang Wu: Risk and predictors of cardiovascular events in early-onset type 2 diabetes: a nationwide, register-based cohort study
OP7 Susanne B Graversen: Fecal occult blood as a marker of cardiovascular risk in diabetes
OP8 Jonas R. Schaarup: Distinct roles of endogenous incretin and glucagon responses to oral glucose tolerance test in association with cardiovascular risk: 11-year follow-up of the ADDITION-PRO study
18:15 - 19:15
EDEG General assembly
19:30 - 21:00
Dinner
Sunday, 10 May
07:00 - 09:00
Breakfast
09:00 - 09:45
Plenary session 2
Chair: Adam Hulmán
Speaker: Robert Wágner
Title: Precision medicine in diabetes mellitus
09:45 - 10:45
Oral presentations (Session 3)
Title: Risk factors of type 2 diabetes
Chair: Rosaria Gesuita & Joline WJ Beulens
OP9 Gertraud Maskarinec: Visceral adipose fat and glycemic status among nako participants with and without a diabetes diagnosis in the German National Cohort (NAKO)
OP10 Sarah Wild: Total cholesterol trajectories following type 2 diabetes diagnosis, in people with versus without severe mental illness
OP11 Omar Silverman-Retana: Does having a spouse living with diabetes affect the trajectories of intrinsic capacity of Mexican older adult couples?
OP12 Tinne Laurberg: Impact of type 2 diabetes duration on stage at diagnosis and mortality in pancreatic cancer: a Danish population-based cohort study (2004–2024)
10:45 - 11:15
Coffee break
11:15 - 12:15
Poster presentations (Session 1)
Title: Descriptive epidemiology and risk factors of diabetes mellitus
Chair: Győző Kocsis
PP1 Jie Zhang: Common biomarkers underlying multimorbidity progression: a longitudinal analysis of 25 biomarkers and disease accumulation in UK BIOBANK
PP2 Kristina Matthiesen Hansen: Prevalence of prediabetes and diabetes based on routine hba1c measurements in the Faroese population aged 30-80 years
PP4 Konstantinos Makrilakis: Impact of ICD-10 Classification Criteria on Estimates of Type 1 Diabetes Prevalence and Incidence in Greece (2019–2021)
PP5 Ramachandran Nanditha: Prevalence of renal insufficiency in patients with type 2 diabetes in southern India – a retrospective analysis of a hospital-based data
PP6 Paula Andreghetto Bracco: Staging intermediate hyperglycaemia for type 2 diabetes prevention – the ELSA-Brasil study
PP7 Andrea Faragalli: Impact of diabetic ketoacidosis at diagnosis on glycaemic outcomes according to automated insulin delivery use in children with type 1 diabetes
PP8 Juley De Smidt: Exploring in utero exposure to teratogens (alcohol and nicotine) in the development of cardiometabolic risk susceptibility in adolescents from rural and urban low-income settings: a comparison study
12:15 - 13:15
Lunch break
13:15 - 14:15
Oral presentations (Session 4)
Title: Lifestyle factors and type 2 diabetes
Chair: Robert Wágner & Stine Byberg
OP13 Joline WJ Beulens: A systematic review and meta-analysis on actionable dietary behaviours and the development of obesity: an observational study
OP14 Rebecca Baqiyyah Conway: Temporal patterns in overweight and obesity in a contemporary cohort with type 1 diabetes
OP15 Christine El-Khoury: Genetic and epigenetic factors modifying the association between diet quality and incident type 2 diabetes: the EPIC-Potsdam cohort
OP16: Lilli Abstein: Healthy and unhealthy plant-based dietary patterns and associations with type 2 diabetes: insights from northern Sweden
14:15 - 15:00
Plenary session 3
Chair: Adam G Tabák
Speaker: Mika Kivimäki
Title: Organ ageing as a driver of cardiovascular, renal, and metabolic disease
15:30 - 18:00
Social outing
18:00 - 19:30
Free time
19:30 - 21:00
Dinner
Monday, 11 May
07:00 - 09:00
Breakfast
09:00 - 09:45
Plenary session 4
Chair: Peter P Harms
Speaker: Femke Rutters
Title: Psychosocial aspects of diabetes mellitus: the first guideline on diabetes distress
09:45 - 10:30
Oral presentations (Session 5)
Title: Psychosocial factors and diabetes mellitus
Chair: Femke Rutters & Charlotte Andriessen
OP17 Annie Jeffery: Effectiveness of primary care psychological therapies for depression and anxiety in adults living with type 2 diabetes
OP18 Romy Slebe: Eating jetlag and glycaemic markers in older dutch adults: a cross-sectional study using data from the Hoorn study
OP20 Sabita Soedamah-Muthu: Psychosocial differences in lifestyle behaviors: a cross-sectional study among people with type 2 diabetes
10:30 - 11:00
Coffee break
11:00 - 12:00
Poster presentations (Session 2)
Title: Psychosocial and socioeconomic factors and diabetes mellitus
Chair: Sabita Soedamah-Muthu
PP9 Jentske Wertwijn: How do people interact with their food environment? A cluster analysis of time-weighted food environment exposure and differences in sociodemographic characteristics and food outlet usage in the general population
PP10 Samantha B.J. Schipper: Interventions to reduce diabetes-related distress among adults with type 1 or type 2 diabetes: systematic review and meta-analyses of randomised controlled trials to inform the first EASD clinical practice guideline
PP11 Anette Andersen: Does health literacy mediate the relationship between socioeconomic status and subjective and objective health in people with type 2 diabetes?
PP12 Juan Pablo Pérez Bedoya: Geospatial association between sociodemographic variables and metabolic control in Colombian patients diagnosed with diabetes mellitus. A cross-sectional ecological study
PP14 Fernando Valentim Bitencourt: Social capital in the association between socioeconomic position and periodontitis in type 2 diabetes
PP15 Edlira Skrami: Diabetes occurs during pregnancy and the role of citizenship. A population-based study in a region of central Italy, 2013-2020 (mighty project - cup p2022asxkr)
12:00 - 13:00
Lunch break
13:00 - 14:00
Oral presentations (Session 6)
Title: Renal disease in type 1 diabetes
Chair: Daniel R Witte & Rasmus Wibaek
OP20 Rasmus Wibaek: Prevalence, incidence and mortality of diabetes from 1996-2024 in Denmark
OP22 Ieva Strele: Personal and familial autoimmune and atopic disease and age-specific incidence of type 1 diabetes
OP23 Christina Ji-Young Lee: Trends in prevalence and incidence of chronic kidney disease in individuals with type 1 diabetes – a Danish nationwide study
OP24 Pernille Falberg Rønn: HbA1c trajectories and risk of albuminuria in children and adolescents with type 1 diabetes followed into adulthood - a joint modeling approach
14:00 - 15:00
Oral presentations (Session 7)
Title: Perinatal and environmental factors and diabetes development
Chair: Ina Danquah & Romy Slebe
OP25 Alexander Lang: The relationship between climate change and diabetes – an umbrella review of systematic reviews
OP26 Emmy Keysendal: Low birth weight and subtypes of type 2 diabetes
OP27 István Panykó: Increasing prevalence of gestational diabetes in Hungary between 2010 and 2017 – a population-based screening program
OP28 Márk M. Svébis: The role and importance of maternal height in the diagnosis of gestational diabetes – a population-based cohort study
15:00 - 15:30
Coffee break
15:30 - 16:30
Poster presentations (Session 3)
Title: Different aspects of diabetes epidemiology from perinatal factors to methodological questions
Chair: Jentske Wertwijn
PP16 Sarah Cuschieri: Diabetes and vertebral fracture risk: evidence of skeletal fragility in a small-state population
PP17 Katja Kemp Jacobsen: Adherence to diabetes screening in high-risk women after gestational diabetes mellitus in Denmark
PP18 Bendix Carstensen: The Lexis machinery in r: practical tools for register research follow-up in multiple states on multiple timescales with
PP19 Lars Jorge Díaz: Interpretation issues in the Mao-Lin/Ghosh-Lin approach to recurrent composite events in the case of a competing terminal event
PP20 Eleftheria Papachristoforou: Changes in pharmacotherapy patterns in patients with type 2 diabetes: a 26-year longitudinal comparison from tertiary diabetes centers in Greece
PP21 Petra J.M. Elders: Evaluating the impact of the implementation of a deprescribing program regarding glucose-lowering medication in primary care
PP22 Marica Iommi: Measuring adherence to diabetes recommendations: time-dependent approaches for estimating the risk of complications in a population-based cohort using secondary data
16:30 - 17:30
Oral presentations (Session 8)
Title: Pharmacotherapy of and chronic kidney disease in type 2 diabetes
Chair: Sarah H Wild & Petra JM Elders
OP29 Charlotte Andriessen: The effect of the implementation of a deprescribing program regarding glucose-lowering medication in primary care on diabetes complications in overtreated elderly with type 2 diabetes: a randomized controlled intervention study
OP30 Georgios Karamanakos: Trends in pharmacotherapy costs and cardiovascular risk factor management in type 2 diabetes: a 26-year study from tertiary diabetes centers in Greece
OP31 Kristin Lundegard: Prediction of chronic kidney disease among Danish adults with type 2 diabetes using a super learner ensemble
OP32 Gregor Maier: Comparative effectiveness of combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists compared with sodium-glucose cotransporter 2 inhibitors in individuals with type 2 diabetes: a prevalent new-user cohort study
17:30 - 17:45
Closing remarks
19:00 - 24:00
Gala dinner
Tuesday, May 12
07:00 - 09:30
Breakfast
09:30 - 10:00
Check out
Speakers
Dr Robert Wágner
Professor of Clinical Research of Diabetes and Metabolism, Heinrich-Heine-University Düsseldorf
Dr Robert Wagner is Professor of Clinical Research of Diabetes and Metabolism and a clinician-scientist at Heinrich-Heine-University Düsseldorf, where he serves as Deputy Director of the Department of Endocrinology and Diabetes at University Hospital Düsseldorf. He also leads the Clinical Research Center at the Institute of Clinical Diabetology, German Diabetes Center (DDZ) (Leibniz Center for Diabetes Research), Düsseldorf. Since 2025, he has served as a Board Member of the European Association for the Study of Diabetes (EASD) and as a Board Member of the German Diabetes Association (DDG).
He studied economics and business administration at the Budapest University of Economics (today Corvinus University of Budapest) and completed his medical degree at Semmelweis University. Following early clinical training in Budapest, he continued his residency and specialist training in Germany, including Internal Medicine in Sigmaringen and subspecialty training in Endocrinology/Diabetology in Tübingen. He earned his Dr. med. with magna cum laude at the University of Tübingen and completed his habilitation (venia legendi) in Internal Medicine there. In 2018, he became board-certified in Internal Medicine, Endocrinology, and Diabetes.
Since 2011, Dr Wagner has been deeply involved in clinical diabetes research and has held several leadership roles spanning academic medicine and large-scale research infrastructures, including positions as senior physician and head of endocrine outpatient services in Tübingen and, subsequently, Head of the Clinical Research Center at Helmholtz Munich’s Institute for Diabetes and Metabolic Research at the Tübingen site. Since 2022, he has led clinical research activities across university medicine and a national diabetes research center in Düsseldorf.
His research is centered on understanding the pathogenetic drivers and heterogeneity of type 2 diabetes, with a focus on pathophysiology-based subphenotyping and the integration of rich clinical and biomarker phenotypes (including laboratory and genetic data), advanced imaging, and computational approaches. His work has contributed to influential publications in the field, including studies on diabetes risk subphenotypes, pancreatic and hepatic fat, and data-driven representations of type 2 diabetes heterogeneity.
Dr Wagner’s achievements have been recognized with multiple awards, including the Werner-Creutzfeldt Prize (2024), the Ferdinand-Bertram Prize (2021), and the Prevention Prize of the German Society of Internal Medicine (DGIM) (2021).
Prof Dr Mika Mika Kivimäki
Chair of Social Epidemiology, University College London, Mental Health of Older People
Professor Mika Kivimaki is an epidemiologist at University College London (UCL) whose research examines how midlife risk factors influence the development of major age-related diseases, including cardiovascular disease, diabetes, dementia, and multimorbidity. He leads the landmark Whitehall II study and coordinates several international multicohort collaborations. Kivimaki is a Highly Cited Researcher.
After his PhD at the University of Helsinki in 1997, Professor Mika Kivimaki set up and directed several large epidemiological cohort studies in Finland before starting collaboration with the prestigious Whitehall II study at UCL, taking over as director in 2007. Using data from Whitehall II and multicohort consortia, such as the IPD-Work consortium of 17 European cohort studies, his aim is to increase understanding of modifiable risk factors and prognostic factors for major chronic diseases, in particular vascular disease, metabolic disorders and dementia.
He is also interested in determinants of functional limitations in later life. His studies have been used as primary evidence for numerous clinical guidelines and policy statements, including European Guidelines on Cardiovascular Disease Prevention in Clinical Practice and the NICE Guideline to Prevent Disability, Dementia and Frailty. In 2018 he was elected a Fellow of the Academy of Medical Sciences.
Dr Femke Rutters
Associate Professor, Amsterdam UMC
Dr. Femke Rutters is an assistant professor at VUmc, interested in the role of psychosocial factors, such as stress, sleep, and circadian misalignment in the development and regulation of Type 2 Diabetes. Dr. Rutters supervises over 8 PhD students, manages the Hoorn studies cohorts, teaches several courses for post-graduate Epidemiology students and Medical students, as well as serving as treasurer for the Epidemiology Diabetes Europe Group. Dr. Rutters currently holds the Senior Fellowship of the Dutch Diabetes Foundation.